Cargando…
The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis
BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study ai...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499991/ https://www.ncbi.nlm.nih.gov/pubmed/36168558 http://dx.doi.org/10.1016/j.heliyon.2022.e10728 |
_version_ | 1784795118635581440 |
---|---|
author | Mahmud, Sultan Mohsin, Md Hossain, Sorif Islam, Md Mynul Muyeed, Abdul |
author_facet | Mahmud, Sultan Mohsin, Md Hossain, Sorif Islam, Md Mynul Muyeed, Abdul |
author_sort | Mahmud, Sultan |
collection | PubMed |
description | BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study aims to inspect the COVID-19 vaccine acceptance rate worldwide and the regional variation of the acceptance rates among the general population and healthcare workers across different territories of the world. In addition, it compares the vaccine acceptance rates between the pre- and post-vaccine approval periods. METHOD: A comprehensive systematic review was conducted using PRISMA statements. After quality evaluation, the data from eligible studies were analyzed using the random effect model. Q-test and [Formula: see text] statistics were used to search for heterogeneity. The publication bias was assessed by using Egger’s test and funnel plot. RESULTS: The combined COVID-19 vaccine acceptance rate among the general population and healthcare workers (n = 1,581,562) was estimated at 62.79% (95% CI: 58.98–66.60). The acceptance rate substantially decreased from 66.29% (95% CI: 61.24–71.35) to 56.69% (95% CI: 48.68–64.71) among the general population from the pre-to post-vaccine approval periods but remained almost constant at 58.25% (95% CI: 46.52–69.97) among healthcare workers. The acceptance rates also varied in different regions of the world. The highest acceptance rate was found in the South-East Asia region at 70.18% (95% CI: 58.12–82.25) and the lowest was found in African Region at 39.51% (95% CI: 23.42–55.59). CONCLUSION: Low COVID-19 vaccine acceptance rate might be a massive barrier to controlling the pandemic. More research is needed to address the responsible factors influencing the low global rate of COVID-19 vaccine acceptance. Integrated global efforts are required to remove the barriers. |
format | Online Article Text |
id | pubmed-9499991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94999912022-09-23 The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis Mahmud, Sultan Mohsin, Md Hossain, Sorif Islam, Md Mynul Muyeed, Abdul Heliyon Research Article BACKGROUND: Vaccination seems to be the most effective way to prevent and control the spread of COVID-19, a disease that has adversely impacted the lives of over 7 billion people across the globe. Vaccine hesitancy represents an important threat to combat infectious diseases worldwide. This study aims to inspect the COVID-19 vaccine acceptance rate worldwide and the regional variation of the acceptance rates among the general population and healthcare workers across different territories of the world. In addition, it compares the vaccine acceptance rates between the pre- and post-vaccine approval periods. METHOD: A comprehensive systematic review was conducted using PRISMA statements. After quality evaluation, the data from eligible studies were analyzed using the random effect model. Q-test and [Formula: see text] statistics were used to search for heterogeneity. The publication bias was assessed by using Egger’s test and funnel plot. RESULTS: The combined COVID-19 vaccine acceptance rate among the general population and healthcare workers (n = 1,581,562) was estimated at 62.79% (95% CI: 58.98–66.60). The acceptance rate substantially decreased from 66.29% (95% CI: 61.24–71.35) to 56.69% (95% CI: 48.68–64.71) among the general population from the pre-to post-vaccine approval periods but remained almost constant at 58.25% (95% CI: 46.52–69.97) among healthcare workers. The acceptance rates also varied in different regions of the world. The highest acceptance rate was found in the South-East Asia region at 70.18% (95% CI: 58.12–82.25) and the lowest was found in African Region at 39.51% (95% CI: 23.42–55.59). CONCLUSION: Low COVID-19 vaccine acceptance rate might be a massive barrier to controlling the pandemic. More research is needed to address the responsible factors influencing the low global rate of COVID-19 vaccine acceptance. Integrated global efforts are required to remove the barriers. Elsevier 2022-09-23 /pmc/articles/PMC9499991/ /pubmed/36168558 http://dx.doi.org/10.1016/j.heliyon.2022.e10728 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Mahmud, Sultan Mohsin, Md Hossain, Sorif Islam, Md Mynul Muyeed, Abdul The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title | The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title_full | The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title_fullStr | The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title_full_unstemmed | The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title_short | The acceptance of COVID-19 vaccine at early stage of development and approval: A global systematic review and meta-analysis |
title_sort | acceptance of covid-19 vaccine at early stage of development and approval: a global systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499991/ https://www.ncbi.nlm.nih.gov/pubmed/36168558 http://dx.doi.org/10.1016/j.heliyon.2022.e10728 |
work_keys_str_mv | AT mahmudsultan theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT mohsinmd theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT hossainsorif theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT islammdmynul theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT muyeedabdul theacceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT mahmudsultan acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT mohsinmd acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT hossainsorif acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT islammdmynul acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis AT muyeedabdul acceptanceofcovid19vaccineatearlystageofdevelopmentandapprovalaglobalsystematicreviewandmetaanalysis |